Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Hypothyroidism × Head & Neck × Clear all

Phase

Phase NA 7 Phase 4 2 Phase 2 2 Phase EARLY_PHASE1 1 Phase 3 1 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Head and Neck Neoplasms 23 Squamous Cell Carcinoma of Head and Neck 21 Mouth Neoplasms 11 Nasopharyngeal Carcinoma 10 Thyroid Neoplasms 8 Oropharyngeal Neoplasms 8 Laryngeal Neoplasms 8 Hypopharyngeal Neoplasms 5 Neoplasms 4 Neoplasm Metastasis 4 Colorectal Neoplasms 4 Carcinoma 4 Thyroid Carcinoma, Anaplastic 3 Thyroid Cancer, Papillary 3 Recurrence 3 Ovarian Neoplasms 3 Neoplasms, Squamous Cell 3 Hematologic Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Stomatitis 2 Salivary Gland Neoplasms 2 Parathyroid Neoplasms 2 Neoplasms by Site 2 Neoplasms by Histologic Type 2 Nasopharyngeal Neoplasms 2 Multiple Myeloma 2 Mucositis 2 Melanoma 2 Lung Neoplasms 2 Glioma 2

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02548715 2022-07-13

LSHT

University of Alberta

Phase 2/3 Withdrawn

Hypothyroidism, Neoplasms, Postoperative Complications

Data powered by HemOnc (CC BY 4.0) Colophon ⚡